Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Events in Cancer Patients Receiving Highly Emetogenic or Moderately Emetogenic Chemotherapy

NCT01366599 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01366599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01366599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Events in Cancer Patients Receiving Highly Emetogenic or Moderately Emetogenic Chemotherapy
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
May 31, 2009
Completion date
July 31, 2009
Enrollment
12,058 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arterial thromboembolic event, cardiovascular event, vomiting